In 2014, CTAAB reviewed and made recommendations to the local health plans regarding five applications; a listing of these applications can be found in this report. This year the board re-engaged the Technology Assessment Committee (TAC) to review the issue of new Hepatitis C treatment protocols. Throughout 2013 and 2014 CTAAB reviewed a total of 8 projects representing more than $32 million in capital costs and nearly $5 million in incremental annual community cost. In early 2014, the board convened a committee of local experts to discuss the issue created by the emergence of new treatment protocols, which while effective, come at a significant cost. As national changes continue to impact our region, CTAAB is continuously improving and striving to improve its processes and structures to align with the current healthcare landscape.
Read the entire report here.